Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Predrag Sikiric

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Journal of Pharmacological Sciences|April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
World Journal of Gastroenterology|January 24, 2018
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insightsAntonija Duzel, Josipa Vlainic, Marko Antunovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as TherapySanja Strbe, Ivan Maria Smoday, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A ReviewDanijel Matek, Irena Matek, Mladen Japjec, et al.
Life Sciences|February 8, 2011
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesionsSpomenko Ilic, Domagoj Drmic, Sandra Franjic, et al.
Inflammopharmacology|July 9, 2024
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotectionPredrag Sikiric, Marko Sever, Ivan Krezic, et al.
Current Pharmaceutical Design|June 9, 2018
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract HealingPredrag Sikiric, Rudolf Rucman, Branko Turkovic, et al.
Current Pharmaceutical Design|July 13, 2018
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone HealingSven Seiwerth, Rudolf Rucman, Branko Turkovic, et al.
Current Neuropharmacology|January 27, 2025
Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in RatsIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Journal of Pharmacological Sciences|April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
World Journal of Gastroenterology|January 24, 2018
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insightsAntonija Duzel, Josipa Vlainic, Marko Antunovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as TherapySanja Strbe, Ivan Maria Smoday, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A ReviewDanijel Matek, Irena Matek, Mladen Japjec, et al.
Life Sciences|February 8, 2011
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesionsSpomenko Ilic, Domagoj Drmic, Sandra Franjic, et al.
Inflammopharmacology|July 9, 2024
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotectionPredrag Sikiric, Marko Sever, Ivan Krezic, et al.
Current Pharmaceutical Design|June 9, 2018
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract HealingPredrag Sikiric, Rudolf Rucman, Branko Turkovic, et al.
Current Pharmaceutical Design|July 13, 2018
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone HealingSven Seiwerth, Rudolf Rucman, Branko Turkovic, et al.
Current Neuropharmacology|January 27, 2025
Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in RatsIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Pageof 12